Literature DB >> 23677515

High incidence of venous thromboembolism despite electronic alerts for thromboprophylaxis in hospitalised cancer patients.

Ramón Lecumberri1, Margarita Marqués, Elena Panizo, Ana Alfonso, Alberto García-Mouriz, Ignacio Gil-Bazo, José Hermida, Sam Schulman, José A Páramo.   

Abstract

Many cancer patients are at high risk of venous thromboembolism (VTE) during hospitalisation; nevertheless, thromboprophylaxis is frequently underused. Electronic alerts (e-alerts) have been associated with improvement in thromboprophylaxis use and a reduction of the incidence of VTE, both during hospitalisation and after discharge, particularly in the medical setting. However, there are no data regarding the benefit of this tool in cancer patients. Our aim was to evaluate the impact of a computer-alert system for VTE prevention in patients with cancer, particularly in those admitted to the Oncology/Haematology ward, comparing the results with the rest of inpatients at a university teaching hospital. The study included 32,167 adult patients hospitalised during the first semesters of years 2006 to 2010, 9,265 (28.8%) with an active malignancy. Appropriate prophylaxis in medical patients, significantly increased over time (from 40% in 2006 to 57% in 2010) and was maintained over 80% in surgical patients. However, while e-alerts were associated with a reduction of the incidence of VTE during hospitalisation in patients without cancer (odds ratio [OR] 0.31; 95% confidence interval [CI], 0.15-0.64), the impact was modest in cancer patients (OR 0.89; 95% CI, 0.42-1.86) and no benefit was observed in patients admitted to the Oncology/Haematology Departments (OR 1.11; 95% CI, 0.45-2.73). Interestingly, 60% of VTE episodes in cancer patients during recent years developed despite appropriate prophylaxis. Contrary to the impact on hospitalised patients without cancer, implementation of e-alerts for VTE risk did not prevent VTE effectively among those with malignancies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23677515     DOI: 10.1160/TH13-02-0131

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

1.  Improved compliance with venous thromboembolism pharmacologic prophylaxis for patients with gynecologic malignancies hospitalized for nonsurgical indications did not reduce venous thromboembolism incidence.

Authors:  Lauren S Prescott; Lisa M Kidin; Rebecca L Downs; David J Cleveland; Ginger L Wilson; Mark F Munsell; Alma Y DeJesus; Katherine E Cain; Pedro T Ramirez; Michael H Kroll; Charles F Levenback; Kathleen M Schmeler
Journal:  Int J Gynecol Cancer       Date:  2015-01       Impact factor: 3.437

2.  Improvement of appropriate pharmacological prophylaxis in hospitalised cancer patients with a multiscreen e-alert system: a single-centre experience.

Authors:  R Figueroa; A Alfonso; J López-Picazo; I Gil-Bazo; A García-Mouriz; J Hermida; J A Páramo; R Lecumberri
Journal:  Clin Transl Oncol       Date:  2018-11-16       Impact factor: 3.405

3.  Assessment of adherence to cancer-associated venous thromboembolism guideline and pharmacist's impact on anticoagulant therapy.

Authors:  Esin Aysel Kandemir; Aygin Bayraktar-Ekincioglu; Saadettin Kilickap
Journal:  Support Care Cancer       Date:  2020-08-10       Impact factor: 3.603

4.  Insights into venous thromboembolism prevention in hospitalized cancer patients: Lessons from a prospective study.

Authors:  Rocío Figueroa; Ana Alfonso; José López-Picazo; Ignacio Gil-Bazo; Alberto García-Mouriz; José Hermida; José Antonio Páramo; Ramón Lecumberri
Journal:  PLoS One       Date:  2018-08-02       Impact factor: 3.240

5.  A multifaceted clinical decision support intervention to improve adherence to thromboprophylaxis guidelines.

Authors:  Tessa Jaspers; Marjolijn Duisenberg-van Essenberg; Barbara Maat; Marc Durian; Roy van den Berg; Patricia van den Bemt
Journal:  Int J Clin Pharm       Date:  2021-03-11

6.  Electronic alerts, comparative practitioner metrics, and education improve thromboprophylaxis and reduce venous thrombosis in community hospitals.

Authors:  Scott C Woller; Scott M Stevens; R Scott Evans; Daniel Wray; John Christensen; Valerie T Aston; Matthew Wayne; James F Lloyd; Emily L Wilson; C Gregory Elliott
Journal:  Res Pract Thromb Haemost       Date:  2018-06-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.